NVO

Novo Nordisk A/S (NVO)

Last Price$88.15.2%
Market Cap$392.3B
LTM Gross Profit
$35.6B
YoY Growth
+25.0%
3Y CAGR
+24.1%
5Y CAGR
+18.5%
Stock quality & Intrinsic value
7/10
30.9% overvalued

Novo Nordisk A/S Gross Profit

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Gross Profit
$4,646.6M
$4,899.8M
$5,887.2M
$6,993.1M
$7,591.8M
$8,723.4M
$10.0B
$11.1B
$12.3B
$13.2B
$13.6B
$14.1B
$14.3B
$14.9B
$15.3B
$16.2B
$18.6B
$21.0B
$28.5B
$35.6B
NVO
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVO and see if it's the right time to invest.
Dive in

Novo Nordisk A/S (NVO) Gross Profit comparison analysis

Crunching data... Almost there!

NVO key stats

USD
DKK
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Novo Nordisk A/S's Gross Profit?

As of today, Novo Nordisk A/S's last 12-month Gross Profit is $35.6B, based on the financial report for Dec 31, 2024 (Q4 2024).

2) What is Novo Nordisk A/S's Gross Profit growth rate?

Over the last year, Novo Nordisk A/S's Gross Profit growth was 25.0%. The average annual Gross Profit growth rates for Novo Nordisk A/S have been 27.3% over the past three years, 18.5% over the past five years.

4) How does Novo Nordisk A/S's Gross Profit growth rate compare to its peers?

Over the last year, Novo Nordisk A/S's Gross Profit growth was 25.0%, which is lower than peer median growth of 44.5%. The list of peers includes REGN, VRTX, INCY, BNTX, BGNE, UTHR, ARGX, ALNY, RPRX, SMMT etc.